investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Novel Strategies to Target Leukemia-Stromal Interactions
Peng Huang
0 Collaborator(s)
Funding source
National Institutes of Health (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Peng Huang
University of Texas MD Anderson Cancer Center
Houston, United States
Related projects
Catherine Ju-Ying Wu
Defining the impact of clonal evolution on chronic lymphocytic leukemia
Leukaemia
Ross L Levine
Role of TET2 mutations in malignant transformation and acute myeloid leukemia
Leukaemia
Derrick J. Rossi
Reprogramming committed blood cells to a hematopoietic stem cell fate
Leukaemia
Hematology and hematologic malignancies
Tomasz Skorski
BCR/ABL-PI-3k-ROS pathway induce genomic instability ....
Leukaemia
Pathology
Hematology and hematologic malignancies
Omar Abdel-Wahab
Role of ASXL1 mutations in myeloid malignancies
Leukaemia
Elizaveta V Benevolenskaya
RBP2 Regulation Through Differential Recruitment to Genomic Loci
Leukaemia
Pathology
Hematology and hematologic malignancies
M. James You
CHARACTERIZATION AND TARGETED THERAPY OF T-ALL DEFICIENT FOR PTEN AND INK4A/ARF
Leukaemia
Wenwei Hu
The Role of LIF, a Novel Negative Regulator of p53, in Colorectal Cancer
Leukaemia
Catherine Ju-Ying Wu
(PQD1) Impact of Cytotoxic and Targeted Therapy on Clonal Evolution of CLL
Leukaemia
Pathology
Hematology and hematologic malignancies